Table 6 Effect of age on UCVA, BCVA, and AOP in patients of group II.

From: Syntonic phototherapy versus part time occlusion for treatment of refractive amblyopia

 

3–7 yrs

8–18 yrs

> 18 yrs

Test value

P-value

Sig.

No. = 3

No. = 8

No. = 9

Pre-treatment

      

UCVA

Mean ± SD

0.80 ± 0.35

0.84 ± 0.35

0.73 ± 0.44

0.147≠

0.864

NS

Range

0.4–1

0.3–1.3

0.2–1.3

BCVA

Mean ± SD

0.50 ± 0.44

0.59 ± 0.39

0.50 ± 0.27

0.154≠

0.858

NS

Range

0.2–1

0.2–1.3

0.2–1

Visit 1

      

UCVA

Mean ± SD

0.40 ± 0.10

0.51 ± 0.36

0.57 ± 0.41

0.237≠

0.792

NS

Range

0.3–0.5

0.1–1.3

0.1–1.1

BCVA

Mean ± SD

0.17 ± 0.15

0.39 ± 0.39

0.33 ± 0.23

0.590≠

0.565

NS

Range

0–0.3

0.1–1.3

0–0.7

AOP

Mean ± SD

2.33 ± 0.58

1.88 ± 0.64

2.00 ± 1.23

0.251≠

0.781

NS

Range

2–3

1–3

0–3

Visit 2

      

UCVA

Mean ± SD

0.15 ± 0.07

0.29 ± 0.22

0.40 ± 0.32

0.851≠

0.446

NS

Range

0.1–0.2

0.1–0.7

0–0.9

BCVA

Mean ± SD

0.15 ± 0.07

0.21 ± 0.22

0.25 ± 0.19

0.227≠

0.800

NS

Range

0.1–0.2

0–0.7

0–0.5

AOP

Mean ± SD

1.67 ± 0.58

1.50 ± 0.76

1.78 ± 1.30

0.153≠

0.859

NS

Range

1–2

1–3

0–3

Visit 3

      

UCVA

Mean ± SD

0.00 ± 0.00

0.13 ± 0.14

0.29 ± 0.23

2.483≠

0.122

NS

Range

0–0

0–0.4

0–0.6

BCVA

Mean ± SD

0.00 ± 0.00

0.04 ± 0.08

0.19 ± 0.16

3.300≠

0.069

NS

Range

0–0

0–0.2

0–0.4

AOP

Mean ± SD

1.00 ± 0.00

1.00 ± 0.82

1.50 ± 1.07

0.618≠

0.553

NS

Range

1–1

0–2

0–3

Visit 4

      

UCVA

Mean ± SD

-

0.15 ± 0.07

0.30 ± 0.14

1.891≠

0.228

NS

Range

-

0.1–0.2

0.1–0.4

BCVA

Mean ± SD

-

0.05 ± 0.07

0.18 ± 0.13

1.654≠

0.255

NS

Range

-

0–0.1

0.1–0.4

AOP

Mean ± SD

-

2.00 ± 0.00

1.83 ± 0.41

0.300≠

0.604

NS

Range

-

2–2

1–2

  1. P-value > 0.05: Non significant; P-value ≤ 0.05: Significant; P-value ≤ 0.01: Highly significant.
  2. ≠: Kruskal-Wallis test.
Back to article page